- Home
- CNTX vs VTSI Comparison
CNTX vs VTSI Comparison
Compare CNTX & VTSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTX
- VTSI
- Stock Information
- Founded
- CNTX 2015
- VTSI 1993
- Country
- CNTX United States
- VTSI United States
- Employees
- CNTX N/A
- VTSI N/A
- Industry
- CNTX Biotechnology: Pharmaceutical Preparations
- VTSI Miscellaneous manufacturing industries
- Sector
- CNTX Health Care
- VTSI Consumer Discretionary
- Exchange
- CNTX Nasdaq
- VTSI Nasdaq
- Market Cap
- CNTX 78.0M
- VTSI 67.3M
- IPO Year
- CNTX 2021
- VTSI N/A
- Fundamental
- Price
- CNTX $0.84
- VTSI $6.20
- Analyst Decision
- CNTX Strong Buy
- VTSI Strong Buy
- Analyst Count
- CNTX 5
- VTSI 1
- Target Price
- CNTX $5.50
- VTSI $7.00
- AVG Volume (30 Days)
- CNTX 197.0K
- VTSI 151.6K
- Earning Date
- CNTX 08-06-2025
- VTSI 08-11-2025
- Dividend Yield
- CNTX N/A
- VTSI N/A
- EPS Growth
- CNTX N/A
- VTSI N/A
- EPS
- CNTX N/A
- VTSI 0.19
- Revenue
- CNTX N/A
- VTSI $26,164,645.00
- Revenue This Year
- CNTX N/A
- VTSI $9.92
- Revenue Next Year
- CNTX N/A
- VTSI $16.54
- P/E Ratio
- CNTX N/A
- VTSI $32.66
- Revenue Growth
- CNTX N/A
- VTSI N/A
- 52 Week Low
- CNTX $0.49
- VTSI $3.57
- 52 Week High
- CNTX $2.75
- VTSI $8.98
- Technical
- Relative Strength Index (RSI)
- CNTX 64.84
- VTSI 49.46
- Support Level
- CNTX $0.82
- VTSI $5.81
- Resistance Level
- CNTX $0.87
- VTSI $6.35
- Average True Range (ATR)
- CNTX 0.07
- VTSI 0.27
- MACD
- CNTX 0.01
- VTSI -0.05
- Stochastic Oscillator
- CNTX 58.27
- VTSI 43.33
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
About VTSI VirTra Inc.
VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company sells and supports the use of force training and marksmanship firearms training systems and accessories for law enforcement, military, or civilian use. Company's The product lany includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire, and other accessories.